VERO

MKT CAP:$578187

Venus Concept Inc.

Market Cap

$578187

Healthcare·Medical - Devices·🇨🇦 Canada·NASDAQ

Healthcare·Medical - Devices·🇨🇦·NASDAQ

Stock Price

$0.27-$1.25 (-82.34%)

Apr 6, 2026

Company Details

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally....

CEO

Rajiv Kanishka Liyanaarchchie De Silva

IPO Date

Oct 12, 2017

Website

www.venusconcept.com

Key Metrics TTM

Revenue

$20M

+1.0% YoY

Net Income

-$21M

EPS (Diluted)

-$156.45

Free Cash Flow

-$20M

Revenue / Share

$130.65

Gross Margin

47.1%

Operating Margin

-98.5%

Net Margin

-103.2%

FCF Margin

-97.9%

P/S

0.0x

P/E

—

Earnings Reports

FY 2018

Nov 5, 2018

$10M-51.7%EPS -$93.75

Q3 2018

Nov 5, 2018

$5M+15.3%EPS -$45.44

Q2 2018

Jul 30, 2018

$5M-5.4%EPS -$48.31

FY 2017

Mar 5, 2018

$21M+36.5%EPS -$153.38

Q4 2017

Mar 5, 2018

$6M+13.1%EPS -$9.78

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 16	$3M	$779.0K	-$5M
Q2 16	$4M	$1M	-$5M
Q3 16	$4M	$1M	-$5M
Q4 16	$5M	$2M	-$4M
Q1 17	$5M	$2M	-$4M
Q2 17	$6M	$2M	-$4M
Q3 17	$4M	$2M	-$5M
Q4 17	$6M	$3M	-$4M
Q2 18	$5M	$3M	-$5M
Q3 18	$5M	$2M	-$6M

Valuation

Quarter	P/S	P/E
Q1 16	—	—
Q2 16	—	—
Q3 16	—	—
Q4 16	154.4x	—
Q1 17	134.7x	—
Q2 17	119.8x	—
Q3 17	116.8x	—
Q4 17	71.9x	—
Q2 18	61.1x	—
Q3 18	59.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 18	-$7M	-$7M
Q1 19	-$6M	-$6M
Q2 19	-$5M	-$5M
Q3 19	-$7M	-$7M
Q4 20	$130.0K	$47.0K
Q1 22	-$12M	-$13M
Q2 22	-$7M	-$7M
Q4 22	-$3M	-$3M
Q1 23	-$6M	-$6M
Q4 23	-$774.0K	-$801.0K
Q1 24	-$3M	-$3M
Q2 24	-$1M	-$1M
Q3 24	-$3M	-$3M
Q1 25	-$6M	-$6M
Q2 25	-$5M	-$6M
Q3 25	-$5M	-$5M

Capital Expenditures

Quarter	CapEx
Q4 18	$45.0K
Q1 19	$346.0K
Q2 19	$7.0K
Q3 19	$14.0K
Q4 20	$83.0K
Q1 22	$157.0K
Q2 22	$94.0K
Q4 22	$39.0K
Q1 23	$70.0K
Q4 23	$27.0K
Q1 24	$25.0K
Q2 24	$22.0K
Q3 24	$4.0K
Q1 25	$35.0K
Q2 25	$162.0K
Q3 25	$17.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 17	+71.8%	+17.8%
Q2 17	+62.7%	+26.9%
Q3 17	+13.6%	-2.4%
Q4 17	+13.1%	+6.6%
Q2 18	+0.0%	+7.6%
Q3 18	-16.8%	+10.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 18	$248.0K	—
Q1 19	$348.0K	—
Q2 19	$370.0K	—
Q3 19	$355.0K	—
Q4 20	$0	—
Q1 22	$443.0K	—
Q2 22	$558.0K	—
Q4 22	$552.0K	—
Q1 23	$481.0K	—
Q4 23	$0	—
Q1 24	$339.0K	—
Q2 24	$239.0K	—
Q3 24	$239.0K	—
Q1 25	$207.0K	—
Q2 25	$137.0K	—
Q3 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 16	$2M	—	—	$4M
Q2 16	$2M	—	—	$4M
Q3 16	$2M	$1M	$3M	—
Q4 16	$2M	$859.0K	$3M	—
Q1 17	$2M	$926.0K	$4M	—
Q2 17	$2M	$1M	$3M	—
Q3 17	$2M	$1M	$3M	—
Q4 17	$2M	$1M	$4M	—
Q2 18	$2M	$2M	$4M	—
Q3 18	$2M	$2M	$4M	—

Revenue by Geography

Quarter	Asia Pacific	E M E A	Rest Of World	United States
Q3 17	$874.0K	$1M	$669.0K	$1M
Q2 18	$2M	$988.0K	$330.0K	$3M
Q3 18	$553.0K	$362.0K	$47.0K	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 17	$7M	$0	$7M
Q2 17	$9M	$0	$9M
Q2 19	$10M	$0	$10M
Q3 19	$9M	$0	$9M
Q1 25	$3M	$0	$3M
Q2 25	$4M	$0	$4M
Q3 25	$6M	$0	$6M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 16	129K	—	—
Q2 16	129K	0.0%	—
Q3 16	102K	-20.8%	—
Q4 16	102K	0.0%	—
Q1 17	102K	0.0%	-20.8%
Q2 17	125K	+21.6%	-3.7%
Q3 17	125K	0.0%	+21.6%
Q4 17	109K	-12.7%	+6.2%
Q2 18	129K	+18.8%	+26.2%
Q3 18	156K	+20.4%	+24.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 16	—	—
Q2 16	—	—
Q3 16	—	—
Q4 16	—	—
Q1 17	—	—
Q2 17	—	—
Q3 17	—	—
Q4 17	$3M	2
Q2 18	$3M	2
Q3 18	$2M	2

Revenue / Employee